Company Presentation
Download our Company PresentationApril 2018
News View all news
Evotec and Bayer advance third endometriosis programme into Phase I clinical development
Hamburg, Germany, 18 Apr 2018
Evotec AG announced today that its multi-target alliance with Bayer has advanced another promising small molecule into Phase I for the treatment of endometriosis, a painful, debilitating reproductive condition that affects approximately 176 million women worldwide.
Read moreBusiness Dev Events View all events
21 April2018
24 April2018
ECCMID 2018
Venue: Madrid, Spain
Organisers: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
4 June2018
7 June2018
2018 BIO International Convention
Venue: Boston, USA
Organisers: Biotechnology Innovation Organization (BIO)
Investor Relations Events View all events
8 May2018
9 May2018
Deutsche Bank 43rd Annual Health Care Conference
Venue: Boston, USA
Organisers: Deutsche Bank
9 May2018
Quarterly Statement Q1 2018